• Home
  • About Us
    • About Us
    • Subscribe
    • Privacy Policy
  • Advertise
    • Advertise On IP Watch
    • Editorial Calendar
  • Videos
  • Links
  • Help

Intellectual Property Watch

Original news and analysis on international IP policy

  • Copyright
  • Patents
  • Trademarks
  • Opinions
  • People News
  • Venues
    • Bilateral/Regional Negotiations
    • ITU/ICANN
    • United Nations – other
    • WHO
    • WIPO
    • WTO/TRIPS
    • Africa
    • Asia/Pacific
    • Europe
    • Latin America/Caribbean
    • North America
  • Themes
    • Access to Knowledge/ Open Innovation & Science
    • Food Security/ Agriculture/ Genetic Resources
    • Finance
    • Health & IP
    • Human Rights
    • Internet Governance/ Digital Economy/ Cyberspace
    • Lobbying
    • Technical Cooperation/ Technology Transfer
  • Health Policy Watch

Consensus On Binding Biodiversity Agreement Elusive, To Reconvene in September

20/07/2010 by Catherine Saez, Intellectual Property Watch 2 Comments

Share this:

  • Click to share on Twitter (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to email this to a friend (Opens in new window)
  • Click to print (Opens in new window)

A last-chance negotiation of a draft protocol text on biodiversity access and benefit-sharing has been given yet another chance as delegates parted ways on Friday in Montreal without an agreement but with a tentative plan to reconvene to try to tie it up before a major UN Convention on Biological Diversity meeting in October.

The seven-day meeting ending Friday was characterised as “very positive” by several participants while the Convention on Biological Diversity issued a press release [pdf] describing the event as the theatre of “major breakthroughs on a text of a legally binding protocol,” and enthusiastically said, “History will recall that the Aichi Nagoya Protocol on access and benefit-sharing was born here in Montreal.”

The resumed ninth meeting of the CBD Ad Hoc Open-ended Working Group on Access and Benefit-Sharing took place in Montreal, Canada from 10-16 July and was meant to finalise the protocol drafted at the previous meeting in Cali, Colombia, in March.

The two meeting co-chairs brewed hopes that the protocol would be finalised in time for its possible adoption at the tenth meeting of the CBD Conference of the Parties in Nagoya, from 18-29 October.

In Montreal last week, delegations achieved two readings of the draft protocol. Many countries proposed amended text during the first reading. This led co-chairs Fernando Casas of Colombia and Timothy Hodges of Canada to issue a revised draft on 13 July with proposed modifications (IPW, Biodiversity/Genetic Resources/Biotech, 16 July 2010).

After the second reading, a text titled “Draft Protocol on Access to Genetic Resources and the Fair and Equitable Sharing of Benefits Arising from Their Utilization to the Convention on Biological Diversity,” was presented at the closing plenary and adopted by the Working Group for the remainder of its discussion.

This last text is from the interregional negotiating group, which consists of up to five representatives from each regional group and two representatives each from indigenous and local communities, civil society, industry and public research groups, plus the president of the Conference of Parties (COP) and the incoming (COP) president. While the text was negotiated in the interregional negotiating group, it is endorsed by the working group as a whole and is thus the working group’s text, according to official sources. Indigenous and local communities are allowed to propose text, but it goes into documents only if it is supported by some countries, a source said.

Resumed ninth meeting documents

Some articles in particular saw divergent opinions and delegations found it difficult to agree, according to sources. These included in particular, Article 5 on access to genetic resources, Article 5bis, on access to traditional knowledge associated with genetic resources and Article 12 on compliance with international and national legislation on access and benefit-sharing.

“After the meeting we are a lot more optimistic than before the meeting,” said a European Union delegate, although many issues remain contentious, he said. For example, on Article 5bis, delegations could not agree on sanctions for the use of traditional knowledge illegally acquired. One of the problems, he said, is that there is no international agreement on the definition of traditional knowledge.

On Article 12.2 on sanctions to address non-compliance with fair and equitable sharing of benefits, countries could not reach agreement, the delegate said. Article 13 on monitoring and reporting the utilisation of genetic resources was not agreed on either, according to the delegate, with the African Group and some Latin American countries insisting on the necessity of checkpoints, disclosure requirements and certificates of compliance. Some delegations like the EU, said that this system would work for some transactions, but not for all, as it would be costly and ineffective and runs against reality. With so many different users, it is not possible to have one-size-fits-all system, the delegate said.

A new issue is a push from the European Union to include guaranteed access to “pathogens” for the World Health Organization in the case of an “emergency situation.” The problem with this, said an African delegate, is that no guarantee has yet been made at the World Health Organization on the sharing of benefits when access is granted. Also at issue, the African delegate said, is that definitions are lacking for ‘pathogens’ and what constitutes an emergency – as well as who gets to decide when one is happening. A EU delegate said an ABS protocol should not prevent a quick response from WHO in case of a virus threat.

Negotiations on an access and benefit-sharing text related to influenza virus have been ongoing at WHO for several years, but legally binding rules on access and benefit sharing have yet to be finalised. There also is an ongoing review of the WHO’s emergency committee, which is facing criticism of the way it decided to declare the 2009 pandemic outbreak.

A separate discussion took place about derivative products from genetic resources, where countries for the first time tried to identify all the parties’ position on the subject. “We just had a very informal discussion to explore common understanding of the parties,” he said.

“There is hope,” François Meienberg of the Berne Declaration told Intellectual Property Watch. “But the main issues will only be resolved in Nagoya, and depending how this will be done, the protocol will be a success or a failure,” he said.

Some issues remain, according to him, such as the “temporal scope,” such as whether the protocol covers genetic resources accessed after the protocol entered into force, or whether any benefits accrued after the protocol entered into force. “This will make a huge difference.” Checkpoints are important, he said. “Without specific mandatory checkpoints like patent offices, market registration, the enforcement of the access and benefit-sharing requirements are an illusion.”

For Lila Feisee, vice president for global intellectual property policy at the Biotechnology Industry Organization (BIO), the new text sill contains the issues that could possibly undermine IP rights leading to research and development financing difficulties. “We will continue to reach out to delegations between now and Nagoya to ensure that whatever is agreed to ultimately will preserve innovation and research and development in the biotech space.”

A tentative date has been set aside for the additional meeting before Nagoya. According to sources, the meeting could take place in September. Montreal and Bangkok were proposed to hold the meeting, according to a source.

Kaitlin Mara contributed to this story.

Share this:

  • Click to share on Twitter (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to email this to a friend (Opens in new window)
  • Click to print (Opens in new window)

Related

Catherine Saez may be reached at csaez@ip-watch.ch.

Creative Commons License"Consensus On Binding Biodiversity Agreement Elusive, To Reconvene in September" by Intellectual Property Watch is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Filed Under: IP Policies, Language, News, Themes, Venues, Biodiversity/Genetic Resources/Biotech, English, Environment, Innovation/ R&D, Patents/Designs/Trade Secrets, Traditional and Indigenous Knowledge, United Nations - other

Comments

  1. Dave Wood says

    30/07/2010 at 6:04 pm

    The long series of CBD meetings on access and benefit-sharing for genetic resources have missed a key point. Most of the most valuable genetic resources for agriculture are now within the control of the FAO International Treaty for Plant Genetic Resources. This covers the so-called Annex I crops agreed by ITPGR negotiators, but also the samples of additional species in the CGIAR genebanks, and also the much more valuable `products of research of the CGIAR plant breeding institutes. Now, remarkably, it also covers every sample of seed deposited by any country and anyone in the International Seed Store in Svalbard (even non-crop seed and medicinal plants). Many developed countries have used this mechanism to place genetic resources not previously covered by the ITPGR under its scope and control. This is the result of the Svalbard Depositor Agreement (Article 7) linking to the FAO ITPGR. There are around 60 countries that have not ratified the ITPGR but have ratified the CBD, for example, Mexico. Right now there are over 92,000 samples of Mexican origin in Svalbard, available from depositors for commercial development and use under ITPGR rules. Payment for certain commercial uses of sample derivatives is due to FAO and not the CBD or countries of origin (the ITPGR does not recognize `country of origin’). Many developed countries – including the USA with its vast genetic resource collections – have deposited in Svalbard.
    My suggestion is that countries like Mexico should ask Norway (controlling Svalbard) to change the `Depositor Agreement’ to better reflect country of origin and to remove over several hundred thousand samples from the control of the ITPGR. If this is not done, the ABS meetings are `shutting the stable door after the horse has flown’.

    Reply

Trackbacks

  1. The long road to Access and Benefit Sharing « the CAS-IP blog says:
    26/07/2010 at 3:46 pm

    […] The Summary & Analysis of the meeting can be found here: http://www.iisd.ca/biodiv/rabs9/.  See also the IP Watch post “Consensus on binding biodiversity agreement elusive; to reconvene in September”. […]

    Reply

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

  • Email
  • Facebook
  • LinkedIn
  • RSS
  • Twitter
  • Vimeo
My Tweets

IPW News Briefs

Saudis Seek Alternative Energy Partners Through WIPO Green Program

Chinese IP Officials Complete Study Of UK, European IP Law

Perspectives on the US

In US, No Remedies For Growing IP Infringements

US IP Law – Big Developments On The Horizon In 2019

More perspectives on the US...

Supported Series: Civil Society And TRIPS Flexibilities

Civil Society And TRIPS Flexibilities Series – Translations Now Available

The Myth Of IP Incentives For All Nations – Q&A With Carlos Correa

Read the TRIPS flexibilities series...

Paid Content

Interview With Peter Vanderheyden, CEO Of Article One Partners

More paid content...

IP Delegates in Geneva

  • IP Delegates in Geneva
  • Guide to Geneva-based Public Health and IP Organisations

All Story Categories

Other Languages

  • Français
  • Español
  • 中文
  • اللغة العربية

Archives

  • Archives
  • Monthly Reporter

Staff Access

  • Writers

Sign up for free news alerts

This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy

Copyright © 2021 · Global Policy Reporting

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.